Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEHUT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,190
Award facts
- Contract value 100% obligated
- $123,190.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $123,190.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026—which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with the DLA Medical Supply Chain, demonstrating capability to fulfill diverse federal medical procurement requirements through competitive processes. The Dupixent delivery represents one of numerous orders under the prime indefinite delivery vehicle, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This contract award reflects DLA's ongoing procurement strategy to secure critical pharmaceutical supplies for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FEHUT?
SPE2DB25FEHUT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FEHUT worth?
The government has obligated $123,190 on SPE2DB25FEHUT.
Is contract SPE2DB25FEHUT an order under another contract?
Yes. SPE2DB25FEHUT is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHUT competed?
The extent of competition for SPE2DB25FEHUT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award